Gaucher's Disease Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Clinical Trials

An Efficacy and Safety Study of AVR-RD-02 Compared to Enzyme Replacement Therapy for Treatment of Gaucher Disease Type 3
Condition:   Gaucher Disease, Type 3 Interventions:   Drug: Gene therapy;   Drug: Enzyme Replacement Agent Sponsor:   AVROBIO Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2023 Category: Research Source Type: clinical trials

Assessment of Neurological Manifestations in Gaucher Disease Patients
Condition:   Gaucher Disease Intervention:   Sponsor:   Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2023 Category: Research Source Type: clinical trials

An Efficacy and Safety Study of AVR-RD-02 Compared to Enzyme Replacement Therapy for Treatment of Gaucher Disease Type 3
Condition:   Gaucher Disease, Type 3 Interventions:   Drug: Gene therapy;   Drug: Enzyme Replacement Agent Sponsor:   AVROBIO Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2023 Category: Research Source Type: clinical trials

Assessment of Neurological Manifestations in Gaucher Disease Patients
Condition:   Gaucher Disease Intervention:   Sponsor:   Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2023 Category: Research Source Type: clinical trials

An Efficacy and Safety Study of AVR-RD-02 Compared to Enzyme Replacement Therapy for Treatment of Gaucher Disease Type 3
Condition:   Gaucher Disease, Type 3 Interventions:   Drug: Gene therapy;   Drug: Enzyme Replacement Agent Sponsor:   AVROBIO Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2023 Category: Research Source Type: clinical trials

Assessment of Neurological Manifestations in Gaucher Disease Patients
Condition:   Gaucher Disease Intervention:   Sponsor:   Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2023 Category: Research Source Type: clinical trials

An Efficacy and Safety Study of AVR-RD-02 Compared to Enzyme Replacement Therapy for Treatment of Gaucher Disease Type 3
Condition:   Gaucher Disease, Type 3 Interventions:   Drug: Gene therapy;   Drug: Enzyme Replacement Agent Sponsor:   AVROBIO Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2023 Category: Research Source Type: clinical trials

Assessment of Neurological Manifestations in Gaucher Disease Patients
Condition:   Gaucher Disease Intervention:   Sponsor:   Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2023 Category: Research Source Type: clinical trials

An Efficacy and Safety Study of AVR-RD-02 Compared to Enzyme Replacement Therapy for Treatment of Gaucher Disease Type 3
Condition:   Gaucher Disease, Type 3 Interventions:   Drug: Gene therapy;   Drug: Enzyme Replacement Agent Sponsor:   AVROBIO Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2023 Category: Research Source Type: clinical trials